MRKR
MRKR
NASDAQ · Biotechnology

Marker Therapeutics Inc

$0.87
-0.03 (-3.33%)
As of Nov 14, 10:56 PM ET ·
Financial Highlights (FY 2026)
Revenue
3.84M
Net Income
-13,176,148
Gross Margin
—
Profit Margin
-343.0%
Rev Growth
-26.7%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — — 65.0% 65.0%
Operating Margin -363.4% -327.1% -4.2% -4.2%
Profit Margin -343.0% -325.8% -4.0% -4.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.84M 5.24M 3.86M 4.10M
Gross Profit — — 2.51M 2.67M
Operating Income -13,965,780 -17,149,954 -161,214 -174,270
Net Income -13,176,148 -16,180,288 -155,305 -171,738
Gross Margin — — 65.0% 65.0%
Operating Margin -363.4% -327.1% -4.2% -4.2%
Profit Margin -343.0% -325.8% -4.0% -4.2%
Rev Growth -26.7% -26.7% +19.6% -4.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 9.32M 9.35M
Total Equity — — 11.45M 10.87M
D/E Ratio — — 0.81 0.86
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -13,962,239 -18,098,140 -205,551 -243,961
Free Cash Flow — — -168,121 -167,490